Literature DB >> 15919056

Transport of anthracyclines and mitoxantrone across membranes by a flip-flop mechanism.

Ronit Regev1, Daniella Yeheskely-Hayon, Hagar Katzir, Gera D Eytan.   

Abstract

The objectives of the present work are to characterize the transport of mitoxantrone and three anthracyclines in terms of binding to the membrane surface, flip-flop across the lipid core of the membrane, and release into the medium. Mitoxantrone and anthracyclines are positively charged amphipathic molecules, and as such are located at the surface of membranes among the headgroups of the phospholipids. Therefore, their transport across membranes occurs by a flip-flop mechanism, rather than by diffusion down a continuous concentration gradient located in the lipid core of the membrane. Flip-flop rates have been estimated with liposomes labeled at their surface with 7-nitrobenzo-2-oxa-1,3-diazol-4-yl (NBD) moiety attached to the headgroup of phosphatidylethanolamine. Flip-flop of mitoxantrone, doxorubicin, daunorubicin, and idarubicin occurred with half-lives of 6, 0.7, 0.15, and 0.1min, respectively. Partition of the drugs into the membrane occurred with lipid phase/aqueous medium coefficients of 230,000, 8600, 23,000, and 40,000 for mitoxantrone, doxorubicin, daunorubicin, and idarubicin, respectively, which are much higher than their corresponding octanol/aqueous medium values. There was no direct correlation between the lipophilicity of the drugs and their lipid phase/aqueous medium partition coefficient or their flip-flop rate. Mitoxantrone exhibited the highest affinity toward liposome membranes, but the slowest flip-flop across the lipid core of the membranes. Simulation of drug uptake into liposomes revealed that transmembrane movement of the mitoxantrone and anthracyclines is determined by their flip-flop rate and affinity toward membranes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919056     DOI: 10.1016/j.bcp.2005.03.032

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  21 in total

1.  Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates To Overcome Cancer Resistance.

Authors:  Gaia Fumagalli; Giulia Giorgi; Máté Vágvölgyi; Eleonora Colombo; Michael S Christodoulou; Veronica Collico; Davide Prosperi; Franco Dosio; Attila Hunyadi; Monica Montopoli; Mariafrancesca Hyeraci; Alessandra Silvani; Giordano Lesma; Lisa Dalla Via; Daniele Passarella
Journal:  ACS Med Chem Lett       Date:  2018-04-17       Impact factor: 4.345

2.  Expanding the chemical diversity of CK2 inhibitors.

Authors:  Renaud Prudent; Virginie Moucadel; Miriam López-Ramos; Samia Aci; Beatrice Laudet; Liliane Mouawad; Caroline Barette; Jacques Einhorn; Cathy Einhorn; Jean-Noel Denis; Gilles Bisson; Frédéric Schmidt; Sylvaine Roy; Laurence Lafanechere; Jean-Claude Florent; Claude Cochet
Journal:  Mol Cell Biochem       Date:  2008-06-18       Impact factor: 3.396

3.  Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery.

Authors:  Kathryn C Partlow; Gregory M Lanza; Samuel A Wickline
Journal:  Biomaterials       Date:  2008-05-16       Impact factor: 12.479

4.  The Flip-Flop Diffusion Mechanism across Lipids in a Hybrid Bilayer Membrane.

Authors:  Christopher J Barile; Edmund C M Tse; Ying Li; John P Gewargis; Nicholas A Kirchschlager; Steven C Zimmerman; Andrew A Gewirth
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

5.  Second Harmonic Generation Spectroscopy of Membrane Probe Dynamics in Gram-Positive Bacteria.

Authors:  Lindsey N Miller; William T Brewer; Julia D Williams; Elizabeth M Fozo; Tessa R Calhoun
Journal:  Biophys J       Date:  2019-09-18       Impact factor: 4.033

6.  Structural effects and translocation of doxorubicin in a DPPC/Chol bilayer: the role of cholesterol.

Authors:  Tyrone J Yacoub; Allam S Reddy; Igal Szleifer
Journal:  Biophys J       Date:  2011-07-20       Impact factor: 4.033

7.  Targeted delivery of doxorubicin through conjugation with EGF receptor-binding peptide overcomes drug resistance in human colon cancer cells.

Authors:  Shibin Ai; Tao Jia; Weilun Ai; Jianli Duan; Yongmei Liu; Jing Chen; Xin Liu; Fan Yang; Yuan Tian; Zebo Huang
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

8.  Modeling cardiac uptake and negative inotropic response of verapamil in rat heart: effect of amiodarone.

Authors:  Pakawadee Sermsappasuk; Osama Abdelrahman; Michael Weiss
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

9.  Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes.

Authors:  Yingna He; Linhua Zhang; Cunxian Song
Journal:  Int J Nanomedicine       Date:  2010-09-20

10.  A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.

Authors:  Ana Catarina Alves; Daniela Ribeiro; Miguel Horta; José L F C Lima; Cláudia Nunes; Salette Reis
Journal:  J R Soc Interface       Date:  2017-08       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.